Yoshikazu Inoue

Yoshikazu Inoue

Auto-generated profile, based on publicly available information

Yoshikazu Inoue

Department of Plastic and Reconstructive Surgery, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2022 in Regenerative Therapy
Verified
Journal Article
Open access
YSYusuke Shimizu
Yusuke Shimizu
ENEdward Hosea Ntege
Edward Hosea Ntege
HSHiroshi Sunami
Hiroshi Sunami
YIYoshikazu Inoue
Yoshikazu Inoue
Hair loss, or alopecia, is associated with several psychosocial and medical comorbidities, and it remains an economic burden to individuals and the society. Alopecia is attributable to varied mechanisms and features a multifactorial predisposition, and the available conventional medical interventions have several limitations. Thus, several therapeutic strategies for alopecia in regenerative medicine are currently being explored, with increasing evidence suggesting that mesenchymal stem cell (MSC) implantation, MSC-derived secretome treatment, and blood-derived platelet-rich plasma therapies are potential treatment options. In this review, we searched the Cochrane Library, MEDLINE (PubMed), EMBASE, and Scopus using various combinations of terms, such as “stem cell,” “alopecia,” “hair loss,” “Androgenetic alopecia,” “male-pattern hair loss,” “female-pattern hair loss,” “regenerative hair growth,” “cell therapy,” “mesenchymal stem cells,” “MSC-derived extracellular vesicles,” “MSC-derived exosomes,” and “platelet-rich plasma” and summarized the most promising regenerative treatments for alopecia. Moreover, further opportunities of improving efficacy and innovative strategies for promoting clinical application were discussed.

8 April 2025 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
HKHitomi Kojima
Hitomi Kojima
HNHiroshi Nishioka
Hiroshi Nishioka
YIYoshikazu Inoue
Yoshikazu Inoue
TOTakayuki Okumoto
Takayuki Okumoto

20 March 2025 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
IKInhoe Ku
Inhoe Ku
TKTaek-Kyun Kim
Taek-Kyun Kim
DCDaekwan Chi
Daekwan Chi
YIYoshikazu Inoue
Yoshikazu Inoue
MIMaki Inukai
Maki Inukai
JJJae-Yong Jeong
Jae-Yong Jeong

19 March 2026 in JPRAS Open
Verified
Journal Article
Open access
HNHiroshi Nishioka
Hiroshi Nishioka
MYMakiko Yamauchi
Makiko Yamauchi
SKSuguru Kondo
Suguru Kondo
YIYoshikazu Inoue
Yoshikazu Inoue
TOTakayuki Okumoto
Takayuki Okumoto
Skeletal relapse after mandibular advancement via sagittal split ramus osteotomy (SSRO) remains a major concern in mandibular retrognathia. While advancement magnitude is frequently implicated, the independent contributions of Frankfort mandibular angle (FMA) and concomitant genioplasty remain debated. This retrospective study included 37 consecutive patients with mandibular retrognathia who underwent SSRO with or without genioplasty (January 2020–December 2024). Lateral cephalograms were obtained preoperatively and at 1 week and 6 months postoperatively. Using the Frankfort horizontal plane and a vertical reference plane through Sella, horizontal and vertical positional changes of B-point, Pogonion, and Menton were measured. Surgical movement was defined as the preoperative to 1-week change; relapse as the 1-week to 6-month change. Multivariate linear regression models included movement magnitude, genioplasty, and preoperative FMA. Exploratory models tested movement × FMA and movement × genioplasty interactions. The cohort was predominantly female (36/37) with a mean age of 28.6 ± 6.4 years and a high mean FMA of 37.0 ± 2.8° Advancement magnitude was the only significant predictor of relapse, at B-point (horizontal and vertical) as well as at Pogonion and Menton (horizontal) (all p < 0.05). Neither FMA nor genioplasty showed independent effects. Interaction terms were not significant; however, visualization suggested a steeper relapse-advancement slope at higher FMA (40° vs 30°). In early follow-up, mandibular advancement magnitude was the primary determinant of skeletal relapse after SSRO for mandibular retrognathia, whereas FMA and genioplasty were not significant independent predictors. However, exploratory visualization suggested a possible advancement–FMA interaction, warranting larger studies to clarify potential effect modification by skeletal pattern.